NL

NL PHARMA

BV

0661.907.808

Founded in 01-09-2016
Normale toestand
Ratio 2022 2021 2020 2019
Summary
Credit limit
€ 6K
€ 4K
€ 4K
€ 3K
Profit
€ 29K
€ 7K
€ 11K
€ 6K
Equity
€ 47K
€ 39K
€ 42K
€ 32K
Gross margin
€ 40K
€ 19K
€ 35K
€ 25K
Dividends
€ 9K
Profitability
EBITDA
€ 38K
€ 17K
€ 29K
€ 23K
EBIT
€ 29K
€ 7K
€ 19K
€ 12K
Net profit
€ 17K
€ -3K
€ 11K
€ 6K
Capex
€ 9K
€ 9K
€ 11K
€ 10K
Liquidity
Cash
€ 4K
€ 4K
€ 10K
€ 2K
Cashflow
€ 26K
€ 7K
€ 21K
€ 16K
Current ratio
1.51
1.22
1.18
0.92
Quick ratio
1.61
1.22
1.21
0.99
Working capital
€ 18K
€ 8K
€ 8K
€ -3K
Working capital ratio
1.56
1.22
1.19
0.96
Solvability
Assets
€ 86K
€ 90K
€ 110K
€ 98K
Amounts payable
€ 39K
€ 50K
€ 68K
€ 66K
Solvability
54.47%
43.75%
38.38%
32.25%
Long term debt ratio
0.10
0.32
0.48
0.88
Interest Coverage Ratio
Rentability
Gross profitability
56.41%
18.87%
49.6%
52.04%
Net profitability
35.66%
-7.62%
25.37%
18.82%
Return On Assets (ROA)
19.42
-3.34
9.74
6.07
Return On Equity (ROE)
35.66
-7.62
25.37
18.82
Efficiency
Customer credit
Supplier credit
Inventory Turnover Ratio
Days Sales Outstanding (DSO)
Days Sales of Inventory (DSI)
Social balance
Employees

Klaar om te starten?

Find out the financial situation of potential customers, suppliers or business partners by consulting official information and key figures.

App screenshot